HPV detection in patients with atypical squamous cells diagnosis in a Mexican population. Comparison of HC2 and PCR tests
Detección de VPH en pacientes con diagnóstico de células escamosas atípicas en una población mexicana. Comparación entre las pruebas HC2 y PCR
Read
6344
Timeswas read the article
972
Total PDF
5372
Total HTML
Share statistics
array:20 [ "pii" => "X1665920110871385" "issn" => "16659201" "estado" => "S300" "fechaPublicacion" => "2010-09-01" "documento" => "article" "crossmark" => 0 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "GAMO. 2010;9:187-92" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3556 "formatos" => array:3 [ "EPUB" => 42 "HTML" => 3086 "PDF" => 428 ] ] "itemSiguiente" => array:16 [ "pii" => "X1665920110871393" "issn" => "16659201" "estado" => "S300" "fechaPublicacion" => "2010-09-01" "documento" => "article" "crossmark" => 0 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "GAMO. 2010;9:193-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5294 "formatos" => array:3 [ "EPUB" => 42 "HTML" => 4681 "PDF" => 571 ] ] "es" => array:12 [ "idiomaDefecto" => true "titulo" => "Exenteración pélvica total en cáncer ginecológico. Análisis de factores pronóstico y resultados quirúrgicos en el Centro Médico Nacional 20 de Noviembre del ISSSTE" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "193" "paginaFinal" => "197" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Total pelvic exenteration in gynecologic cancer. Analysis of prognosis factors and surgical results in the Centro Medico Nacional 20 de Noviembre of ISSSTE" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "305v09n05-13187139fig1.jpg" "Alto" => 837 "Ancho" => 1012 "Tamanyo" => 48759 ] ] "descripcion" => array:1 [ "es" => "Distribución de los casos por diagnóstico." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Juan Alberto Tenorio-Torres, Beatriz Arcelia Ortega-Meza, Seir Alfonso Cortés-Cárdenas" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Juan Alberto" "apellidos" => "Tenorio-Torres" ] 1 => array:2 [ "nombre" => "Beatriz Arcelia" "apellidos" => "Ortega-Meza" ] 2 => array:2 [ "nombre" => "Seir Alfonso" "apellidos" => "Cortés-Cárdenas" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X1665920110871393?idApp=UINPBA00004N" "url" => "/16659201/0000000900000005/v0_201306121353/X1665920110871393/v0_201306121354/es/main.assets" ] "itemAnterior" => array:16 [ "pii" => "X1665920110871377" "issn" => "16659201" "estado" => "S300" "fechaPublicacion" => "2010-09-01" "documento" => "article" "crossmark" => 0 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "GAMO. 2010;9:185-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1848 "formatos" => array:3 [ "EPUB" => 28 "HTML" => 1495 "PDF" => 325 ] ] "es" => array:9 [ "idiomaDefecto" => true "titulo" => "Imagen del oncólogo médico actual" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "185" "paginaFinal" => "186" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "The medical oncologist current image" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Valle S. Aura Erazo" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Valle S." "apellidos" => "Aura Erazo" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X1665920110871377?idApp=UINPBA00004N" "url" => "/16659201/0000000900000005/v0_201306121353/X1665920110871377/v0_201306121353/es/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "titulo" => "HPV detection in patients with atypical squamous cells diagnosis in a Mexican population. Comparison of HC2 and PCR tests" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "187" "paginaFinal" => "192" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Hallmann Rita Sotelo-Regil, Marcela Lizano-Soberón, Adela Carrillo-García, Itzel Saldaña-Santamaría, Alejandro García-Carrancá, Margarita Ibarra-del Río, Lorena Flores-Hernández" "autores" => array:7 [ 0 => array:3 [ "nombre" => "Hallmann Rita" "apellidos" => "Sotelo-Regil" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "nombre" => "Marcela" "apellidos" => "Lizano-Soberón" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 2 => array:3 [ "nombre" => "Adela" "apellidos" => "Carrillo-García" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 3 => array:3 [ "nombre" => "Itzel" "apellidos" => "Saldaña-Santamaría" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 4 => array:3 [ "nombre" => "Alejandro" "apellidos" => "García-Carrancá" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 5 => array:3 [ "nombre" => "Margarita" "apellidos" => "Ibarra-del Río" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 6 => array:3 [ "nombre" => "Lorena" "apellidos" => "Flores-Hernández" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Departamento de Citopatología, Instituto Nacional de Cancerología, México. " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Unidad de Investigación Biomédica en Cáncer. Instituto Nacional de Cancerología, México and Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México. " "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Detección de VPH en pacientes con diagnóstico de células escamosas atípicas en una población mexicana. Comparación entre las pruebas HC2 y PCR" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "305v09n05-13187138fig1.jpg" "Alto" => 862 "Ancho" => 2083 "Tamanyo" => 258578 ] ] "descripcion" => array:1 [ "en" => "ASC diagnosis: a) Papanicolaou staining: altered intermediate cell with nuclear growth 2.5-3 times the size of the nucleus of a normal intermediate cell (400x). b) Papanicolaou staining: altered deep cell, with slight growth and nuclear irregularity, slight hyperchromatism (400x)." ] ] ] "textoCompleto" => "<span class="elsevierStyleBold">¿ INTRODUCTION</span> <p class="elsevierStylePara">Cancer of the uterine cervix affects nearly 500 000 women worldwide;<span class="elsevierStyleSup">1</span> Mexico has one of the highest incidence (40 × 100 000 females)<span class="elsevierStyleSup">2</span> and mortality rates (17 × 100 000 inhabitants) for this type of cancer.<span class="elsevierStyleSup">3</span> It has been demonstrated that more than 90% of cervical carcinomas are associated with persistent infections of oncogenic genotypes of the human papillomavirus (HPV), mainly types 16 and 18.<span class="elsevierStyleSup">4</span></p> <p class="elsevierStylePara">Despite that intensive early-detection campaigns have been conducted in Mexico for more than 30 years,<span class="elsevierStyleSup">3</span> it has not been possible to diminish the incidence or mortality of this disease since the sensitivity of conventional cytology is low (50-60%).<span class="elsevierStyleSup">2</span></p> <p class="elsevierStylePara">In order to increase the sensitivity of screening methods, new ancillary techniques have been implemented at a national level in Mexico. Among these are liquid-based cytology and molecular biology tests.</p> <p class="elsevierStylePara">Hybrid capture test (HC2), which detects 13 of the most frequent genotypes of the high-risk HPV virus, is the molecular biology test accepted by the Federal Drug Administration (FDA) since the year 2003.<span class="elsevierStyleSup">5,6</span> This study has the following indications: a) patients with a cytological diagnosis of atypical squamous cells (ASC); b) post-treatment follow-up; and c) as a support of cytological cervical screening in women over 30 years of age.<span class="elsevierStyleSup">2</span> </p> <p class="elsevierStylePara">Several studies have also included polymerase chain reaction (PCR) HPV diagnosis as a reinforcement of HC2 test, due to its high sensitivity.<span class="elsevierStyleSup">2,5,7,8</span></p> <p class="elsevierStylePara">The first indication to perform these tests is a cytological interpretation of ASC. This term was introduced by the Bethesda System of Reporting Cervical Cytology in 1988<span class="elsevierStyleSup">9</span> and modified in 2001.10 </p> <p class="elsevierStylePara">In the U.S.A. this diagnosis is reported in nearly two million women annually,<span class="elsevierStyleSup">5</span> and in the National Cancer Institute in Mexico City, in 1-1.5% of reviewed cytologies.<span class="elsevierStyleSup">11</span> The term ASC refers to borderline lesions that surpass the reactive processes but that do not bring together the requirements for diagnosis of a low-grade intraepithelial lesion that requires strict follow-up. </p> <p class="elsevierStylePara"> Cytomorphological criteria for diagnosing ASC are well established, but are subjective.<span class="elsevierStyleSup">10 </span>Therefore, an overdiagnosis of this entity predominates, with the consequent increase in colposcopy studies, and unnecessary treatments with excessive costs.<span class="elsevierStyleSup">12 </span></p> <p class="elsevierStylePara">The objective of the present work was to evaluate whether cytomorphological criteria used in diagnosis of ASC at the National Cancer Institute of Mexico correlate with the presence of high-risk HPV types, justifying thus the performance of molecular biology tests (HC2 and/or PCR) for follow-up of only positive cases. </p> <p class="elsevierStylePara"><span class="elsevierStyleBold">¿METHODS</span></p> <p class="elsevierStylePara">This study included 100 patients selected with a cytological report of ASC. This diagnosis was performed with conventional cytology applied to patients assisting to theGynecological Department of the National Cancer Institute of Mexico from 2007-2008. Patients signed a letter of informed consent. Exclusion criteria included the following: refusal to participate in the study and insufficient sample amount for molecular diagnosis. A prospective, observational, and transversal study was conducted. We considered the following as risk factors: age; number of sexual partners, and age of first sexual intercourse (FSI).</p> <p class="elsevierStylePara">Patients diagnosed with ASC were required for a new sample for molecular biology studies: HC2, and PCR.</p> <p class="elsevierStylePara">Initial conventional cytology was carried out with an Ayre spatula and cervical brush from exocervix and transformation zone. The sample was fixed with 96% alcohol and stained according to the Papanicolaou technique. For HC2 and PCR tests, samples were taken with a cervical brush and fixed in STM Digene Liquid and 1 ml Lysis buffer (Tris-HCl 10 mmol/L pH 8.0, EDTA 0.1 mol/L pH 8-0, SDS 0.5%, Proteinase K 200 μg/mL, RNase A 20 μg/mL), respectively.</p> <p class="elsevierStylePara">Initial ASC diagnosis was made during routine laboratory work with conventional cytology samples stained with the Papanicolaou technique, screened by a senior cytotechnologist, and reviewed by an experienced cytopathologist. </p> <p class="elsevierStylePara">The cytological diagnostic criteria were uniform according to the Bethesda System of Reporting Cervical Cytology 2001<span class="elsevierStyleSup">10</span> guidelines, which state that an ASC should show an increase in nuclear size of 2.5-3 times related to the nucleus of normal intermediate cells, slight irregularity in the nuclear contour and a slight change in the chromatin pattern (<span class="elsevierStyleBold">Figures 1a, b</span>).</p> <p class="elsevierStylePara"> <img src="305v09n05-13187138fig1.jpg" alt="Figure 1. ASC diagnosis: a) Papanicolaou staining: altered intermediate cell with nuclear growth 2.5-3 times the size of the nucleus of a normal intermediate cell (400x). b) Papanicolaou staining: altered deep cell, with slight growth and nuclear irregularity, slight hyperchromatism (400x)."/></p> <p class="elsevierStylePara"><span class="elsevierStyleBold"> Figure 1. </span>ASC diagnosis: a) Papanicolaou staining: altered intermediate cell with nuclear growth 2.5-3 times the size of the nucleus of a normal intermediate cell (400x). b) Papanicolaou staining: altered deep cell, with slight growth and nuclear irregularity, slight hyperchromatism (400x).</p> <p class="elsevierStylePara">HPV DNA detection by the HC2 method (Digene Co., Gaithersburg, MD, USA) comprises a single stranded DNA hybridized with RNA probes directed to high- and intermediate-risk viruses (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68), and a chemioluminiscent detection of the signal. PCR is an enzymatic amplification of DNA that allows the detection of very low levels of DNA copies through an exponential amplification of a selected region. For HPV detection samples were digested with 1 mL of lysis buffer at 55 ºC for 3 h. DNA was extracted with phenol/chloroform precipitations as described by Sambrook <span class="elsevierStyleItalic">et al.</span><span class="elsevierStyleSup">13</span> As extended DNA quality control DNA was amplified for ß-globin gene (PCO4/ GH2O) under conditions described by Resnick <span class="elsevierStyleItalic">et al.</span><span class="elsevierStyleSup">14</span> Samples were later submitted to HPV amplification with three sets of the following universal primers recognizing distinct size fragments of L1 gene: L1C1/L1C2, MY09/ MY11, and GP5/GP6.<span class="elsevierStyleSup">15,16</span> DNA extracted from CaSkiand Hela-HPV positive cell lines were used as positive controls. Each amplification reaction was carried out in a 20-μl volume containing 2 mM dNTPs, 0.5 U de Amplitaq Gold DNA polymerase, 1.5-3.0 mM of MgCl<span class="elsevierStyleInf">2</span>, buffer 10X, 10 pM of each oligonucleotide, and water. Temperatures of denaturation, alignment, and extension depended on the oligonucleotide set employed. HPV PCR products were electrophoresed in a 1.2%agarose gel and visualized by ethidium bromide staining.HPV typing was carried out by direct sequencing ofPCR products by means of the BigDye<span class="elsevierStyleSup">TM</span> Terminatorv3.1 Cycle Sequencing Kit (Applied Biosystems). Theresulting sequences were analyzed in BLAST data bankfor comparison with known HPV sequences.</p> <p class="elsevierStylePara"><span class="elsevierStyleItalic">Kappa</span> agreement between the two tests (HC2/ PCR) was calculated.<span class="elsevierStyleSup">17</span> Cytological diagnosis data (ASC) and positivity for HC2 and PCR tests were correlated with clinicopathological variables analyzed. Patient follow-up was carried out at least for one year. </p> <p class="elsevierStylePara"><span class="elsevierStyleBold">¿ RESULTS</span></p> <p class="elsevierStylePara">Age of the 100 patients included in this study ranged between 18 to 80 years, with a mean of 43 years and a median of 46 years. Descriptive values of the studied variables according to its relation with presence or absence of HPV, were analyzed. Risk factors for developing squamous intraepithelial lesions (SIL) and/or carcinoma considered in this study were the following: age, number of sexual partners, and age at first sexual intercourse. Forty one patients (41%) declared one sexual partner. First sexual intercourse was declared in a range between 11-49 years, with an average age of 27 years and a median age of 20 years. Variables were analyzed in order to find any association with HPV positivity. Neither of the variables showed any significant association, including declared number of sexual partners. </p> <p class="elsevierStylePara"><span class="elsevierStyleBold">Table 1</span> shows a comparative analysis of HC2 and PCR for HPV DNA detection. A total of 40% of the patients were HPV positive by any assay. Particularly, the PCR assay detected 35 HPV positive cases, while HC2 test detected 24 positive cases. 19% of the samples resulted HPV positive for both tests, as 60% were negative for both test. Meanwhile, 21% had a discordant result (16 % were only positive for PCR amplification; and 5% were only positive by HC2). Kappa value was 0.502 (IC 95% 0.313-0.691) with 50.2% of agreement between the two methods, which was greater than that expected by chance; hence the interpretation was a moderate agreement, and the significance level was <span class="elsevierStyleItalic">p </span> <0 0001 with 95 confidence intervals of 0 313-0 691</0></p> <p class="elsevierStylePara"> <img src="305v09n05-13187138fig2.jpg" alt="Table 1. Comparison of HPV detection by HC2 assay and PCR in patients with ASC diagnosis. No. of samples with the following results"/></p> <p class="elsevierStylePara">Viral genotypes were identified by direct sequencing of PCR products. Correlations with HC2 findings are shown in <span class="elsevierStyleBold">Table 2</span>. Cases with viral genotypes 11, 62, 81, and 102 were found negative in CH2 test, which is explained by the fact that these viral types are not included among the 13 genotypes detected by this method. Nevertheless, two cases positive to HPV53, one to HPV66, and one to HPV82, tested positive also for CH2 even though these viral types are neither included in the geno-types detected by HC2 test. </p> <p class="elsevierStylePara"> <img src="305v09n05-13187138fig3.jpg" alt="Table 2. Identification of viral genotypes by PCR test and correlation with HC2 in patients with a cytological diagnosis of ASC."/></p> <p class="elsevierStylePara">Clinical or histopathological data of patients with one-year follow-up is shown in <span class="elsevierStyleBold">Table 3</span>. Most of the patients continued asymptomatic (90/100). Seven of them presented aceto-positive colposcopical lesions; ten, atrophic epithelia; and 4 patients presented nuclear enlargement due to chemo (QT)- or radiotherapy (Rt). The most important observation was that obtained for 10 cases that developed SIL (squamous intraepithelial lesion) or cervical carcinoma in one-year follow-up. In <span class="elsevierStyleBold">Table 4</span> are disclosed the histopathological diagnosis of these ten cases and their correlation with HPV results. Seven cases resulted positive for high-risk HPV types, as classified by de Villiers <span class="elsevierStyleItalic">et al</span>,<span class="elsevierStyleSup">18</span> (HPV types 53, 16, 52, 51, 18, and 58), from which only four were detected by HC2. However, three precursor lesions: one cervical intraepithelial lesion (CIN-1), one vaginal intraepithelial lesion (VIEL-1); and one CIN-2 resulted HPV negative by both tests. </p> <p class="elsevierStylePara"> <img src="305v09n05-13187138fig4.jpg" alt="Table 3. Histopathological diagnosis and follow-up of patients with an initial diagnosis of ASC. "/></p> <p class="elsevierStylePara"> <img src="305v09n05-13187138fig5.jpg" alt="Table 4. Identification of viral genotypes in ten patients with an initial diagnosis of Atypical squamous cells (ASC) and histopathological diagnosis of CIN and/or carcinoma."/></p> <p class="elsevierStylePara"><span class="elsevierStyleBold">¿ DISCUSSION</span> </p> <p class="elsevierStylePara">In cervical cytology screening, atypical squamous cells of undetermined significance (ASC-US) is an equivocal category assigned to specimens with morphologic changes suggestive of cervical intraepithelial neoplasia but which may also represent non-neoplastic conditions of various causes.<span class="elsevierStyleSup">5,9,10</span> Therefore, it is a borderline lesion that requires strict follow-up. Cytological diagnostic parameters for this entity are subjective and if interpretation is incorrect, it can give rise to an over or under diagnosis with the consequent expensive follow-up and patient miss-treatment. In the USA, two million women are diagnosed with ASC annually.<span class="elsevierStyleSup">5</span> The cost of follow-up and overtreatment of these patients is very high. Kulansingam and colleagues<span class="elsevierStyleSup">12</span> report that performing a colposcopy in every women with a cytological diagnosis of ASC is more expensive than performing it exclusively in women with cytological diagnosis of ASC and HPVDNA positive test ($20 370 <span class="elsevierStyleItalic">vs.</span> $3117dollars (USD) / HSIL diagnosed case).</p> <p class="elsevierStylePara">Since quality assurance for the interpretation of ASC is important, international guidelines recommend that ASC diagnosis should correspond to no more than 5% of the laboratory cytological material, or that the ASC diagnosed cases should be no more than 2-3 times the number of SIL cases.<span class="elsevierStyleSup">10 </span>In such sense, is relevant to mention that at the cytopathology laboratory of the National Cancer Institute of Mexico, one to 1.5% of the studies (with a mean of 15 cases per month) are reported as ASC.<span class="elsevierStyleSup">11</span> Nevertheless, it is clear that the ASC/SIL ratio as a measure of quality assurance may be an imperfect tool due to the subjective parameters used in the cytological diagnosis of ASC. Therefore, as other authors have proposed,<span class="elsevierStyleSup">12,19</span> HPV DNA testing may be helpful to improve follow-up triage. Different authors cite that 34 to 50% of ASC diagnosed cases will be positive for high-risk HPV DNA.<span class="elsevierStyleSup">19,20</span></p> <p class="elsevierStylePara">Lörincz <span class="elsevierStyleItalic">et al</span><span class="elsevierStyleSup">5</span> mention the benefits of DNA HPV tests, since HC2 tested positive in 100% of HGSIL, compared with 84% of HGSIL detection by means of liquid-based cytology tests and 58% of conventional cytology tests. More recently, as reported in the ASCUS/Low-grade intraepithelial lesions study (ALTS),<span class="elsevierStyleSup">19</span> HC2 sensitivity was 96.3% compared with 85.3% for liquid-based cytology. </p> <p class="elsevierStylePara">Zahn <span class="elsevierStyleItalic">et al</span><span class="elsevierStyleSup">6</span> consider that the combination of cervical cytology and DNA HPV tests is more sensitive for detecting HGSIL than any of the methods separately. These tests may reduce the diagnosis of invasive carcinomas in 90-92%, compared with 89% of conventional cytology, and may increase the negative predictive value up to 99-100%,<span class="elsevierStyleSup">2 </span>which would justify the extension of the screening interval to approximately five years. </p> <p class="elsevierStylePara">It is important to be aware that HPV DNA results can differ depending on the techniques used. In this study we considered necessary to analyze if the morphological changes found in ASC diagnosed cases were associated to an HPV DNA positive test. We were also interested in comparing both tests, HC2 and PCR, for HPV detection in those samples.</p> <p class="elsevierStylePara">Sixty four percent of cases in the Guo series<span class="elsevierStyleSup">8</span> and 40% in our study were positive for one or both tests performed (HC2 and PCR). Meanwhile, 60% of our cases resulted HPV DNA negative by the two methods employed. When comparing results obtained by both tests, we found a 21% of disagreement between HC2 and PCR tests. These data are similar to that shown by Cañadas <span class="elsevierStyleItalic">et al,</span><span class="elsevierStyleSup">7 </span>who also compare both tests obtaining a 16% of discordant results.</p> <p class="elsevierStylePara">According to Meijer et al,<span class="elsevierStyleSup">4</span> patients who test negative for HPV DNA have a minimum risk of developing SIL and/or carcinoma (40-50% lesser risk in 5 years), suggesting the HC2 performance to conduct follow-up studies exclusively in patients positive for high-risk viral genotypes.</p> <p class="elsevierStylePara">We found that HC2 technique detects a less number of positive cases (24 HPV DNA positive women) than those detected with PCR (35 HPV-positive women), as reported by Cañadas <span class="elsevierStyleItalic">et al</span>.<span class="elsevierStyleSup">7</span> This discrepancy can be attributed to a higher sensitivity of the PCR method, which can detect a very low number of viral copies. However, according to several authors, a very low number of copies may have no risk of progression.<span class="elsevierStyleSup">4</span></p> <p class="elsevierStylePara">The five PCR- and HC2+ cases can be explained by cross-reactions with other genotypes, generally of low risk, which are not efficiently detected by the PCR oligonucleotides. Otherwise, failures in PCR amplifications due to deletions or sequence intra-type variations can also affect the PCR result, affording a false-negative.<span class="elsevierStyleSup">7</span></p> <p class="elsevierStylePara">Is worth to mention that HPV-16 was the most prevalent genotype found in our study (20.6% of the HPV DNA positive cases), followed by HPV-51 (11.7%), and the third place with similar proportions were for HPV-18, -31, -53, and 58. Uncommon types as HPV-102, -82 and -81, were also found.</p> <p class="elsevierStylePara">The 60% of HPV DNA negative may be over diagnosed ASC cases, as suggested by Meijer.<span class="elsevierStyleSup">4</span> Nevertheless, three precursor lesions detected at the one year follow-up, resulted negative for HPV by both tests. Two of the latter cases corresponded to low-grade SIL (CIN-1 and VIEL-1), which may have a low risk of progression.<span class="elsevierStyleSup">21</span> However, the third case was a high-grade SIL (CIN-2), which may mean a false negative of both HPV detection methods. When trying to explain the possible causes of ASC over diagnosis, we found that 10 women were in the fifth decade of life, with atrophic epithelia. These atrophic morphological changes may be miss-interpreted as ASC because cervical atrophy is frequently accompanied by exaggerated nuclear growths. Four percent of patients had been previously treated with radiotherapy (Rt) and/or chemotherapy (Qt), which also have been associated with nuclear growth. However, the majority of miss-diagnosed cases (69 patients) may correspond to borderline inflammatory lesions that possibly may need no follow-up.</p> <p class="elsevierStylePara">Follow-up of HPV DNA positive patients is necessary. Different authors report that during 2 years, 60% of patients become HPV negative during this period and have no risk of developing SIL and/or carcinoma. Whereas according to different series, 10-36% of patients with a cytological diagnosis of ASC and positive for high-risk virus develop high grade SIL.<span class="elsevierStyleSup">14,16</span></p> <p class="elsevierStylePara">In conclusion, the percentage of diagnosis of ASC at the Department of Cytopathology at the National Cancer Institute of Mexico remains within the parameters accepted by the international literature.<span class="elsevierStyleSup">9</span> Nevertheless, only 40% of the cases included in this study were positive to HPV DNA, possibly meaning an over diagnosis of ASC in the majority of HPV negative cases. Seven of ten cases that in a one-year follow-up progressed to SIL or cervical cancer, were positive to high-risk HPV types. These results justify the performance of molecular biology tests, preferably both HC2 and PCR, in ASC diagnosed patients, to strictly follow-up those with HPV DNA positive results. </p> <p class="elsevierStylePara"><span class="elsevierStyleBold">¿ ACKNOWLEDGEMENTS</span></p> <p class="elsevierStylePara">This work was partially supported by CONACyT grant 69875. We thank Dr. Sergio Ponce-de-Leon for statistical assistance. </p> <hr/> <p class="elsevierStylePara"> <span class="elsevierStyleItalic">Correspondence:</span> Dra. Rita Sotelo Regil Hallmann.<br/> Av. San Fernando N° 22. Col. Sección XVI, Tlalpan 14080 Mexico, D.F. Mexico.<br/> Telephone/fax: 5628 0468.<br/> <span class="elsevierStyleItalic">E-mail:</span> <a href="mailto:rsotelo24@hotmail.com" class="elsevierStyleCrossRefs">rsotelo24@hotmail.com</a></p> " "pdfFichero" => "305v09n05a13187138pdf001.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec176402" "palabras" => array:1 [ 0 => "Cáncer cervical, ASC, HPV, HC2, PCR, México" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec176401" "palabras" => array:1 [ 0 => "Cervical cancer, ASC, HPV, HC2, PCR, Mexico" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:1 [ "resumen" => "Objective: To evaluate whether the cytomorphological criteria used in the diagnosis of ASC at the National Cancer Institute in Mexico City correlate with HPV DNA positive tests. Methods: Cervical samples from 100 patients with a previous diagnosis of ASC were processed for molecular biology studies by means of HC2 and PCR. Kappa agreement was calculated between the two diagnostic methods. Results: Sixty percent of patients were negative for both tests, 19% were positive for both tests, and 21% exhibited discrepancies. Kappa value was 0.502 (50.2%) of agreement between the two methods. In one-year follow-up studies, ten patients showed SIL or carcinoma, being 7 of them positive to HR-HPV. Conclusions: ASC is over diagnosed by cytological criteria. Even though a small percentage of cases may escape from detection, molecular biology HPV tests in all patients with a cytological report of ASC may be helpful to detect progressive lesions." ] "es" => array:1 [ "resumen" => "Objetivo: Evaluar si los criterios citomorfológicos utilizados en el diagnóstico citológico de ASC en el Instituto Nacional de Cancerología, México, correlacionan con pruebas positivas para la detección de DNA de virus del papiloma humano. Métodos: Se seleccionaron 100 muestras de pacientes con diagnóstico citológico de ASC las cuales se procesaron para estudios biomoleculares (CH2 y PCR). Se calculó la concordancia Kappa entre los dos métodos diagnósticos. Resultados: Fueron negativas para ambas pruebas 60% de las pacientes; fueron positivas para ambas pruebas 19% y mostraron discrepancia 21%. El valor Kappa fue 0.502 (50.2%) de concordancia entre los dos métodos diagnósticos. En un año de seguimiento, 10 pacientes desarrollaron LIE o carcinoma, siete de ellas fueron positivas a virus de alto riesgo. Conclusiones: La entidad ASC está sobre diagnosticada con los criterios citológicos. Aunque un porcentaje pequeño de los casos puede escapar la detección, la biología molecular con pruebas para detectar VPH en pacientes con diagnóstico de ASC es útil en la detección de lesiones progresivas." ] ] "multimedia" => array:5 [ 0 => array:8 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "305v09n05-13187138fig1.jpg" "Alto" => 862 "Ancho" => 2083 "Tamanyo" => 258578 ] ] "descripcion" => array:1 [ "en" => "ASC diagnosis: a) Papanicolaou staining: altered intermediate cell with nuclear growth 2.5-3 times the size of the nucleus of a normal intermediate cell (400x). b) Papanicolaou staining: altered deep cell, with slight growth and nuclear irregularity, slight hyperchromatism (400x)." ] ] 1 => array:8 [ "identificador" => "tbl1" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "305v09n05-13187138fig2.jpg" "imagenAlto" => 570 "imagenAncho" => 1004 "imagenTamanyo" => 68310 ] ] ] ] ] "descripcion" => array:1 [ "en" => "Comparison of HPV detection by HC2 assay and PCR in patients with ASC diagnosis. No. of samples with the following results" ] ] 2 => array:8 [ "identificador" => "tbl2" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "305v09n05-13187138fig3.jpg" "imagenAlto" => 1179 "imagenAncho" => 1020 "imagenTamanyo" => 142084 ] ] ] ] ] "descripcion" => array:1 [ "en" => "Identification of viral genotypes by PCR test and correlation with HC2 in patients with a cytological diagnosis of ASC." ] ] 3 => array:8 [ "identificador" => "tbl3" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "305v09n05-13187138fig4.jpg" "imagenAlto" => 762 "imagenAncho" => 1000 "imagenTamanyo" => 103177 ] ] ] ] ] "descripcion" => array:1 [ "en" => "Histopathological diagnosis and follow-up of patients with an initial diagnosis of ASC." ] ] 4 => array:7 [ "identificador" => "fig2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "305v09n05-13187138fig5.jpg" "Alto" => 950 "Ancho" => 1020 "Tamanyo" => 133244 ] ] "descripcion" => array:1 [ "en" => "3187138fig5.jpg" width="1020" height="950" alt="Table 4. Identification of viral genotypes in ten patients with an initial diagnosis of Atypical squamous cells (ASC) and hist" ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:21 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Human papillomavirus triage of patients with atypical squamous cells of undetermined significance on cervical Papa-nicolaou smear." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Kirby TO" 1 => "Huh WK" 2 => "Partridge EE." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "Ann Acad Med Singapore 2003" "volumen" => "32" "paginaInicial" => "590" "paginaFinal" => "6" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Screening for cervical cancer: new alternatives and research." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Lörincz AT." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "Salud Pública Mex 2003" "volumen" => "45" "paginaInicial" => "S376" "paginaFinal" => "S387" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Segundo consenso de patología del tracto genital inferior y colposcopía." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Ochoa Carrillo FJ." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "Gac Mex Oncol 2006" "volumen" => "5" "paginaInicial" => "85" "paginaFinal" => "6" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 year and older." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Meijer CJL.M" 1 => "Berkof J" 2 => "Castle PE" 3 => "Hesselink AT" 4 => "Franco EL" 5 => "Ronco G" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "Int J Cancer 2009" "volumen" => "124" "paginaInicial" => "516" "paginaFinal" => "20" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Lörincz AT" 1 => "Richart RM." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "Arch Pathol Lab Med 2003" "volumen" => "127" "paginaInicial" => "959" "paginaFinal" => "68" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Human papillomavirus DNA testing as an adjunct in primary screening: is it prime time? Editorial by the American College of Obstetricians and Gynecologists." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Zahan CM." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Lippincott Williams and Wilkins" "fecha" => "2004" "volumen" => "pp 617-8" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Evaluación de las técnicas de detección del VPH en los programas de cribado para el cáncer de cuello uterino." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Cañadas MP" 1 => "Lloveras B" 2 => "Lörincz A" 3 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "Salud Pública Mex 2006" "volumen" => "48" "paginaInicial" => "373" "paginaFinal" => "8" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal PAP results." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Guo M" 1 => "Lin CY" 2 => "Gong Y" 3 => "Cogdell DE" 4 => "Zhang W" 5 => "Lin E" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "Mod Pathol 2008" "volumen" => "21" "paginaInicial" => "1037" "paginaFinal" => "43" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Acta Cytol 1989." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "National Cancer Institute Workshop: The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "volumen" => "33" "paginaInicial" => "567" "paginaFinal" => "574" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "The Bethesda System for Reporting Cervical Cytology. Springer." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Solomon D" 1 => "Nayar R." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "2nd ed" "fecha" => "2004" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Correlación citohistológica en el Instituto Nacional de Cancerología en el año 2006." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Sotelo-Regil HR" 1 => "Ibarra del Río M" 2 => "Flores HL." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "Patología 2008" "volumen" => "46" "paginaInicial" => "309" "paginaFinal" => "14" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Cost effectiveness analysis based on the atypical squamous cells of undetermined significance/low grade squamous intraepithelial lesion triage study (ALTS)." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Kulansingam SL" 1 => "Kim JJ" 2 => "Lawrence WF" 3 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "J Natl Cancer Inst 2006" "volumen" => "98" "paginaInicial" => "82" "paginaFinal" => "3" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Molecular cloning: a laboratory manual. 2nd ed." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Sambrook J" 1 => "Fritsch EF" 2 => "Maniatis T." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "New York: Cold Spring Harbor Laboratory Press, 1989:9" "fecha" => "16" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Resnick R" 1 => "Cornelissen M" 2 => "Wright D" 3 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "J Natl Cancer Inst 1990" "volumen" => "82" "paginaInicial" => "1477" "paginaFinal" => "84" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Husnjak K" 1 => "Grce M" 2 => "Magdic L" 3 => "Paveli K." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "J Virol Methods 2000" "volumen" => "88" "paginaInicial" => "125" "paginaFinal" => "34" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Utilidad en la combinación de oligonucleótidos universales para la detección del virus del papiloma humano en cáncer cervicouterino y lesiones premalignas." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Carrillo A" 1 => "Mohar A" 2 => "Meneses A" 3 => "Frías-Mendivil M" 4 => "Solorza G" 5 => "Lizano M." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "Salud Pública México 2004" "volumen" => "46" "paginaInicial" => "7" "paginaFinal" => "15" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Methods in observational epidemiology." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Keksey J" 1 => "Thompson D" 2 => "Evans A." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Oxford: Oxford University Press, 1986" "fecha" => "pp 285-308" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Classification of Papillomaviruses." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "de Villiers EM" 1 => "Fauquet C" 2 => "Broker TR" 3 => "Bernard HU" 4 => "zur Hausen H." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "Virol 2004" "volumen" => "324" "paginaInicial" => "17" "paginaFinal" => "24" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "The ASCUS-LSIL Triage Study (ALTS) Group." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "Am J Obstet Gynecol 2003" "volumen" => "188" "paginaInicial" => "1383" "paginaFinal" => "92" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Outcomes of women with ASC-US interpretation and positive for high risk HPV DNA." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Feng J" 1 => "Husain M." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "A two-year follow up study in a single institution" "fecha" => "Acta Cytol 2007" "volumen" => "51" "paginaInicial" => "730" "paginaFinal" => "4" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Chapter 11: Squamous carcinoma of the uterine cervix and its precursors. pp 282-394. In: Koss'' Diagnostic Cytology and its Histopathologic Bases. 2006." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Koss LG" 1 => "Melamed MR." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "5th ed" "fecha" => "Lippincott Williams and Wilkins" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16659201/0000000900000005/v0_201306121353/X1665920110871385/v0_201306121354/en/main.assets" "Apartado" => array:4 [ "identificador" => "11762" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Artículos originales" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/16659201/0000000900000005/v0_201306121353/X1665920110871385/v0_201306121354/en/305v09n05a13187138pdf001.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X1665920110871385?idApp=UINPBA00004N" ]
Article information
ISSN: 16659201Original language: English
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 5 | 0 | 5 |
| 2024 October | 39 | 11 | 50 |
| 2024 September | 53 | 4 | 57 |
| 2024 August | 41 | 4 | 45 |
| 2024 July | 36 | 5 | 41 |
| 2024 June | 60 | 7 | 67 |
| 2024 May | 41 | 8 | 49 |
| 2024 April | 28 | 4 | 32 |
| 2024 March | 52 | 6 | 58 |
| 2024 February | 39 | 4 | 43 |
| 2024 January | 72 | 6 | 78 |
| 2023 December | 74 | 12 | 86 |
| 2023 November | 81 | 10 | 91 |
| 2023 October | 90 | 12 | 102 |
| 2023 September | 66 | 1 | 67 |
| 2023 August | 43 | 6 | 49 |
| 2023 July | 44 | 7 | 51 |
| 2023 June | 67 | 17 | 84 |
| 2023 May | 77 | 12 | 89 |
| 2023 April | 68 | 1 | 69 |
| 2023 March | 52 | 9 | 61 |
| 2023 February | 44 | 16 | 60 |
| 2023 January | 46 | 11 | 57 |
| 2022 December | 37 | 8 | 45 |
| 2022 November | 57 | 19 | 76 |
| 2022 October | 39 | 17 | 56 |
| 2022 September | 44 | 9 | 53 |
| 2022 August | 39 | 12 | 51 |
| 2022 July | 35 | 9 | 44 |
| 2022 June | 26 | 8 | 34 |
| 2022 May | 22 | 26 | 48 |
| 2022 April | 35 | 9 | 44 |
| 2022 March | 57 | 12 | 69 |
| 2022 February | 58 | 3 | 61 |
| 2022 January | 59 | 9 | 68 |
| 2021 December | 26 | 19 | 45 |
| 2021 November | 30 | 10 | 40 |
| 2021 October | 37 | 13 | 50 |
| 2021 September | 48 | 11 | 59 |
| 2021 August | 37 | 15 | 52 |
| 2021 July | 16 | 6 | 22 |
| 2021 June | 16 | 9 | 25 |
| 2021 May | 15 | 7 | 22 |
| 2021 April | 44 | 16 | 60 |
| 2021 March | 37 | 12 | 49 |
| 2021 February | 22 | 19 | 41 |
| 2021 January | 17 | 14 | 31 |
| 2020 December | 24 | 15 | 39 |
| 2020 November | 29 | 8 | 37 |
| 2020 October | 26 | 10 | 36 |
| 2020 September | 17 | 11 | 28 |
| 2020 August | 35 | 8 | 43 |
| 2020 July | 19 | 9 | 28 |
| 2020 June | 11 | 3 | 14 |
| 2020 May | 17 | 6 | 23 |
| 2020 April | 8 | 4 | 12 |
| 2020 March | 19 | 4 | 23 |
| 2020 February | 23 | 4 | 27 |
| 2020 January | 20 | 7 | 27 |
| 2019 December | 23 | 5 | 28 |
| 2019 November | 10 | 11 | 21 |
| 2019 October | 15 | 5 | 20 |
| 2019 September | 31 | 15 | 46 |
| 2019 August | 11 | 0 | 11 |
| 2019 July | 20 | 13 | 33 |
| 2019 June | 58 | 41 | 99 |
| 2019 May | 172 | 49 | 221 |
| 2019 April | 81 | 18 | 99 |
| 2019 March | 4 | 8 | 12 |
| 2019 February | 7 | 4 | 11 |
| 2019 January | 6 | 2 | 8 |
| 2018 December | 3 | 3 | 6 |
| 2018 November | 4 | 0 | 4 |
| 2018 October | 6 | 13 | 19 |
| 2018 September | 9 | 1 | 10 |
| 2018 August | 6 | 3 | 9 |
| 2018 July | 3 | 3 | 6 |
| 2018 June | 1 | 3 | 4 |
| 2018 May | 11 | 0 | 11 |
| 2018 April | 5 | 1 | 6 |
| 2018 February | 6 | 0 | 6 |
| 2018 January | 4 | 0 | 4 |
| 2017 December | 7 | 0 | 7 |
| 2017 November | 2 | 1 | 3 |
| 2017 October | 6 | 2 | 8 |
| 2017 September | 5 | 3 | 8 |
| 2017 August | 11 | 3 | 14 |
| 2017 July | 7 | 0 | 7 |
| 2017 June | 7 | 1 | 8 |
| 2017 May | 13 | 1 | 14 |
| 2017 April | 9 | 0 | 9 |
| 2017 March | 11 | 33 | 44 |
| 2017 February | 10 | 5 | 15 |
| 2017 January | 2 | 0 | 2 |
| 2016 December | 4 | 2 | 6 |
| 2016 November | 6 | 1 | 7 |
| 2016 October | 8 | 1 | 9 |
| 2016 September | 8 | 2 | 10 |
| 2016 August | 10 | 1 | 11 |
| 2016 July | 13 | 2 | 15 |
| 2016 June | 59 | 4 | 63 |
| 2016 May | 33 | 1 | 34 |
| 2016 April | 30 | 5 | 35 |
| 2016 March | 34 | 2 | 36 |
| 2016 February | 29 | 6 | 35 |
| 2016 January | 30 | 8 | 38 |
| 2015 December | 62 | 2 | 64 |
| 2015 November | 43 | 3 | 46 |
| 2015 October | 46 | 4 | 50 |
| 2015 September | 49 | 4 | 53 |
| 2015 August | 49 | 1 | 50 |
| 2015 July | 57 | 4 | 61 |
| 2015 June | 41 | 0 | 41 |
| 2015 May | 46 | 2 | 48 |
| 2015 April | 40 | 9 | 49 |
| 2015 March | 39 | 4 | 43 |
| 2015 February | 43 | 1 | 44 |
| 2015 January | 52 | 2 | 54 |
| 2014 December | 72 | 2 | 74 |
| 2014 November | 37 | 2 | 39 |
| 2014 October | 60 | 1 | 61 |
| 2014 September | 66 | 1 | 67 |
| 2014 August | 47 | 0 | 47 |
| 2014 July | 74 | 3 | 77 |
| 2014 June | 82 | 2 | 84 |
| 2014 May | 25 | 2 | 27 |
| 2014 April | 39 | 1 | 40 |
| 2014 March | 60 | 3 | 63 |
| 2014 February | 71 | 7 | 78 |
| 2014 January | 70 | 3 | 73 |
| 2013 December | 51 | 7 | 58 |
| 2013 November | 34 | 5 | 39 |
| 2013 October | 29 | 6 | 35 |
| 2013 September | 24 | 10 | 34 |
| 2013 August | 24 | 5 | 29 |
| 2013 July | 28 | 6 | 34 |
| 2013 June | 20 | 4 | 24 |
| 2013 May | 25 | 8 | 33 |
| 2013 April | 28 | 8 | 36 |
| 2013 March | 23 | 3 | 26 |
| 2013 February | 7 | 3 | 10 |
| 2013 January | 16 | 2 | 18 |
| 2012 December | 7 | 1 | 8 |
| 2012 November | 8 | 2 | 10 |
| 2012 October | 8 | 3 | 11 |
| 2010 August | 601 | 0 | 601 |
Show all